These suggestions are consistent with the clinical findings indicating the presence of aortic and mitral valve diseases and aortic aneurysm in the LDS patients with genetic mutations in TGFB2 (LDS4) or TGFB3 (LDS5) [9,38,48]. The gene discussed is TGFB3; the disease is mitral valve disorder.